Edgardo Alania/Secardiologia.es
Sep 4, 2026, 02:18
Edgardo Alania: Edoxaban in Intracranial Haemorrhage Survivors with AF
Edgardo Alania, Cardiologist at Hospital Marina Salud (Denia), shared a post on X:
“ENRICH-AF (n is equal to 948): Edoxaban after intracranial haemorrhage did not reduce stroke or systemic embolism (11.8% vs 12.8%; HR 0.88) but increased major bleeding (11.6% vs 5.2%; HR 2.23).
Routine edoxaban is not supported in this unselected population.”
Stay updated with Hemostasis Today.
-
Oct 19, 2026, 19:44Where You Live Should not Determine Whether You Receive Care – World Federation of Hemophilia
-
Oct 19, 2026, 19:42Belen Bianco: Prevention, Early Suspicion and an Interdisciplinary Approach Save Lives
-
Oct 19, 2026, 19:40Christina Chrysohoou: Catheter-Based LAAC vs OAC for Stroke Prevention in Atrial Fibrillation
-
Oct 19, 2026, 19:38Matthew Flick: A Two-Day Research Meeting on Fibrinogen, Hemostasis and Thrombosis
-
Oct 19, 2026, 19:37Hayat Saeed: Excited to Share Our Publication on the FGL1–Hepcidin Axis in Iron Homeostasis and Disease
-
Oct 19, 2026, 19:08IPAW 2026 Comes to a Close, but the Work Continues – PPTA
-
Oct 19, 2026, 17:44Paul Riley: Moderating a Webinar on Anticoagulation Monitoring
-
Oct 19, 2026, 16:36Christopher Pittman: Blood Clot Prevention Cannot End at Hospital Discharge
-
Oct 19, 2026, 16:13Javier M. Floren: When Immune Cells Move With Their Environment